Rodabe Amaria

Clinical trials

• PROSECCO: A Phase 2, Single Arm, Neoadjuvant Study Evaluating Combination Cemiplimab, Fianlimab, And Ipilimumab In Patients With Surgically Resectable Melanoma

  Principal investigator · Not yet recruiting · Phase 2

  M.D. Anderson Cancer Center

  2026–2030
• A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors

  Principal investigator · Recruiting · Phase 1, Phase 2

  M.D. Anderson Cancer Center

  2024–2041
• A Phase 1/2 Study of KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid Tumors

  Principal investigator · Active not recruiting · Phase 1, Phase 2

  M.D. Anderson Cancer Center

  2024–2029
• Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma

  Principal investigator · Active not recruiting · Phase 1

  M.D. Anderson Cancer Center

  2022–2027